C. Peet

Key Mutations Alter the Cytochrome P450 BM3 Conformational Landscape and Remove Inherent Substrate Bias*

A. Munro, D. Leys, M. Voice, 2013, The Journal of Biological Chemistry.

Role of aldehyde oxidase in biogenic amine metabolism.

J. Smith, C. Beedham, G. Panoutsopoulos, 1995, Progress in brain research.

Discovery of sodium 6-[(5-chloro-2-{[(4-chloro-2-fluorophenyl)methyl]oxy}phenyl)methyl]-2-pyridinecarboxylate (GSK269984A) an EP(1) receptor antagonist for the treatment of inflammatory pain.

A. Naylor, W. Winchester, A. Hall, 2009, Bioorganic & medicinal chemistry letters.

Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis

Juan A. Bueren-Calabuig, Andrei V. Pisliakov, David W. Gray, 2019, Proceedings of the National Academy of Sciences.

Pharmacokinetics of β-Lactam Antibiotics: Clues from the Past To Help Discover Long-Acting Oral Drugs in the Future

Paul W Smith, Robert H Bates, K. Read, 2018, ACS infectious diseases.

Human P450-like oxidation of diverse proton pump inhibitor drugs by 'gatekeeper' mutants of flavocytochrome P450 BM3.

K. Fisher, A. Munro, D. Leys, 2014, The Biochemical journal.

Identification of enzymes involved in Phase I metabolism of ciclesonide by human liver microsomes

R. Nave, C. Peet, M. Hall, 2005, European Journal of Drug Metabolism and Pharmacokinetics.

Pharmacokinetics of β-Lactam Antibiotics

Robert H Bates, K. Read, F. Zuccotto, 1983 .